American Society of Hematology/hematology.org
Aug 31, 2026, 14:23
Accelerating CAR-T Access Through Policy and System Reform – American Society of Hematology
American Society of Hematology shared a post on LinkedIn:
“Meaningful progress in access to CAR-T will require not only continued scientific innovation, but also coordinated policy reform, regulatory collaboration, and sustained investment in modernizing the systems that ultimately determine who benefit from these transformative therapies.
Read more in The Hematologist.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes